Related Experiment Video
Updated: Apr 27, 2026
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
New recommendations in prostate cancer screening and treatment
Lisa K Adams1, Lindsay S Ferrington
1Lisa K. Adams practices hematology/oncology at Feist-Weiller Cancer Center in Shreveport, La., and is a recent graduate of the PA program at Louisiana State University's Health Sciences Center in Shreveport, La. Lindsay S. Ferrington is an instructor in the Louisiana State University PA program. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Prostate cancer is the most commonly diagnosed nonskin cancer in men, with 233,000 new cases estimated for 2014. Nearly 30,000 deaths are predicted for 2014, second only to lung and bronchial cancer deaths. Early diagnosis is key to improving patient survival rates. Screening efforts have dramatically increased the detection rate, and now, 90% of new diagnoses are caught at the early stage of disease. However, new data are driving controversial changes to screening and treatment recommendations.
More Related Videos
Related Concept Videos
01:20Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:30Preventive Healthcare Services
02:59Cancer Prevention